نتایج جستجو برای: chamomile vaginal gel

تعداد نتایج: 134450  

Journal: :The Journal of infectious diseases 2000
B C Herold N Bourne D Marcellino R Kirkpatrick D M Strauss L J Zaneveld D P Waller R A Anderson C J Chany B J Barham L R Stanberry M D Cooper

Presently marketed vaginal barrier agents are cytotoxic and damage the vaginal epithelium and natural vaginal flora with frequent use. Novel noncytotoxic agents are needed to protect women from sexually transmitted diseases. One candidate compound is a high-molecular-mass form of soluble poly(sodium 4-styrene sulfonate) (T-PSS). The antimicrobial activity of T-PSS was evaluated in primary cultu...

2015
Steven E. Chavoustie Mark Jacobs Howard A. Reisman Arthur S. Waldbaum Sharon F. Levy Sharon L. Hillier Paul Nyirjesy

OBJECTIVE Metronidazole vaginal gel (MVG) 0.75% is a US Food and Drug Administration-approved, 5-day treatment for bacterial vaginosis (BV). This study tested the hypothesis that a shorter treatment course at a higher dose (MVG 1.3%) would yield similar efficacy to 5 days of MVG 0.75%. MATERIALS AND METHODS This phase 2, multicenter, randomized, controlled, investigator-blinded, dose-ranging ...

2012
Marla J. Keller Colleen A. Carpenter Yungtai Lo Mark H. Einstein Congzhou Liu David N. Fredricks Betsy C. Herold

BACKGROUND Acidform gel, an acid-buffering product that inactivates spermatozoa, may be an effective topical non-hormonal contraceptive. This study was designed to evaluate the safety of vaginal dosing and effects of Acidform on mucosal immune mediators, antimicrobial properties of genital secretions, and vaginal microbiota. METHODS Thirty-six sexually abstinent U.S. women were randomized to ...

Journal: :BMJ 2006
Jodie M Dodd Caroline A Crowther Jeffrey S Robinson

OBJECTIVE To compare oral misoprostol solution with vaginal prostaglandin gel (dinoprostone) for induction of labour at term to determine whether misoprostol is superior. DESIGN Randomised double blind placebo controlled trial. SETTING Maternity departments in three hospitals in Australia. Population Pregnant women with a singleton cephalic presentation at > or = 36+6 weeks' gestation, with...

Journal: :The Journal of infectious diseases 2015
Rachel A Bender Ignacio Tara Perti Amalia S Magaret Sharanya Rajagopal Claire E Stevens Meei-Li Huang Stacy Selke Christine Johnston Jeanne Marrazzo Anna Wald

BACKGROUND Tenofovir is a potent anti-human immunodeficiency virus (HIV) agent that decreased risk of herpes simplex virus type 2 (HSV-2) acquisition in HIV pre-exposure prophylaxis trials. Whether tenofovir has utility in established HSV-2 disease is unclear. METHODS We randomized immunocompetent women with symptomatic HSV-2 infection to oral tenofovir disoproxil fumarate (TDF)/placebo vagin...

Journal: :Acta pharmaceutica 2004
Zeljka Pavelić Natasa Skalko-Basnet Ivan Jalsenjak

The aim of our study was to develop a liposomal carrier system for the local treatment of bacterial vaginosis, capable to efficiently deliver entrapped drug during an extended period of time. Chloramphenicol was entrapped in liposomes composed of egg phosphatidylcholine/egg phosphatidylgycerol-sodium (9:1, molar ratio) and prepared by two different methods, the proliposome method and the polyol...

Journal: :AIDS 1998
C Coggins C J Elias R Atisook M T Bassett V Ettiègnene-Traoré P D Ghys L Jenkins-Woelk E Thongkrajai N L VanDevanter

Objective: There is an urgent need for safe, effective and acceptable vaginal barrier methods for the prevention of sexually transmitted diseases (STDs), including HIV. A variety of existing spermicides have the potential to be used both for prevention of STDs and unwanted pregnancy. Unfortunately, very little is known about formulation preferences and the desirable characteristics of vaginal p...

2013
Sidi Yang Yufei Chen Kaien Gu Alicia Dash Casey L Sayre Neal M Davies Emmanuel A Ho

The goal of this study was to develop and characterize an intravaginal nanomedicine for the active targeted delivery of saquinavir (SQV) to CD4(+) immune cells as a potential strategy to prevent or reduce HIV infection. The nanomedicine was formulated into a vaginal gel to provide ease in self-administration and to enhance retention within the vaginal tract. SQV-encapsulated nanoparticles (SQV-...

Journal: :Journal of the American Board of Family Medicine : JABFM 2012
Dilek Uygur Tolga Guler Eyup Yayci Tijen Atacag Cem Comunoglu Gamze Mocan Kuzey

PURPOSE To determine the effects of lubrication of the vaginal speculum before insertion during a Papanicolaou test on perceived pain and quality of the cytology specimen. METHODS Four hundred eligible women participating in cervical cancer screening and an early detection program were randomized with respect to lubricant gel use before speculum insertion. Perceived pain during speculum inser...

2014
Larisa Kizima Aixa Rodríguez Jessica Kenney Nina Derby Olga Mizenina Radhika Menon Samantha Seidor Shimin Zhang Keith Levendosky Ninochka Jean-Pierre Pavel Pugach Guillermo Villegas Brian E. Ford Agegnehu Gettie James Blanchard Michael Piatak Jeffrey D. Lifson Gabriela Paglini Natalia Teleshova Thomas M. Zydowsky Melissa Robbiani José A. Fernández-Romero

Prevalent infection with human herpes simplex 2 (HSV-2) or human papillomavirus (HPV) is associated with increased human immunodeficiency virus (HIV) acquisition. Microbicides that target HIV as well as these sexually transmitted infections (STIs) may more effectively limit HIV incidence. Previously, we showed that a microbicide gel (MZC) containing MIV-150, zinc acetate (ZA) and carrageenan (C...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید